Ghent University Academic Bibliography

Advanced

HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy

Hugo De Vuyst, Flavia Lillo, Nathalie Broutet and Jennifer S. Smith (2008) EUROPEAN JOURNAL OF CANCER PREVENTION. 17(6). p.545-554
abstract
The objective of this study was to review the literature on the epidemiological association between human papillomavirus (HPV), HIV, and cervical neoplasia, and the impact of highly active antiretroviral therapy (HAART) on this association. MEDLINE was searched using the terms 'human papillomavirus, 'HPV, 'HIV', 'cervix, 'neoplasm', and 'antiretroviral' to identify articles published before December 2006. HIV-infection was strongly associated with a higher prevalence, incidence, and persistence of HPV infection and correlated with prevalence, incidence, persistence, and progression of squamous intraepithelial lesions. The association between HIV and invasive cervical carcinoma has been more difficult to establish, but is now fully recognized. HAART seems to have little, if any, beneficial effect on the natural history of intraepithelial lesions in HIV-positive women. Despite this fact, HAART, does increase the life expectancy of HIV-positive women. Therefore, it remains important to closely monitor HPV-related disease in women with HIV who are receiving HAART, particularly in regions of the world where cervical screening is not available routinely.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (review)
publication status
published
keyword
ONCOGENIC HUMAN-PAPILLOMAVIRUS, human papillomavirus, SQUAMOUS INTRAEPITHELIAL LESIONS, human immunodeficiency virus, POSITIVE WOMEN, SEROPOSITIVE WOMEN, highly active antiretroviral therapy, HUMAN-IMMUNODEFICIENCY-VIRUS, HIGH-RISK, INFECTED WOMEN, SERONEGATIVE WOMEN, NATURAL-HISTORY, cervical neoplasia, HPV INFECTIONS
journal title
EUROPEAN JOURNAL OF CANCER PREVENTION
Eur. J. Cancer Prev.
volume
17
issue
6
pages
545 - 554
Web of Science type
Review
Web of Science id
000260810600007
JCR category
ONCOLOGY
JCR impact factor
1.865 (2008)
JCR rank
106/141 (2008)
JCR quartile
4 (2008)
ISSN
0959-8278
DOI
10.1097/CEJ.0b013e3282f75ea1
language
English
UGent publication?
yes
classification
A1
id
747047
handle
http://hdl.handle.net/1854/LU-747047
date created
2009-09-09 09:05:54
date last changed
2010-01-11 14:01:59
@article{747047,
  abstract     = {The objective of this study was to review the literature on the epidemiological association between human papillomavirus (HPV), HIV, and cervical neoplasia, and the impact of highly active antiretroviral therapy (HAART) on this association. MEDLINE was searched using the terms 'human papillomavirus, 'HPV, 'HIV', 'cervix, 'neoplasm', and 'antiretroviral' to identify articles published before December 2006. HIV-infection was strongly associated with a higher prevalence, incidence, and persistence of HPV infection and correlated with prevalence, incidence, persistence, and progression of squamous intraepithelial lesions. The association between HIV and invasive cervical carcinoma has been more difficult to establish, but is now fully recognized. HAART seems to have little, if any, beneficial effect on the natural history of intraepithelial lesions in HIV-positive women. Despite this fact, HAART, does increase the life expectancy of HIV-positive women. Therefore, it remains important to closely monitor HPV-related disease in women with HIV who are receiving HAART, particularly in regions of the world where cervical screening is not available routinely.},
  author       = {De Vuyst, Hugo and Lillo, Flavia and Broutet, Nathalie and Smith, Jennifer S.},
  issn         = {0959-8278},
  journal      = {EUROPEAN JOURNAL OF CANCER PREVENTION},
  keyword      = {ONCOGENIC HUMAN-PAPILLOMAVIRUS,human papillomavirus,SQUAMOUS INTRAEPITHELIAL LESIONS,human immunodeficiency virus,POSITIVE WOMEN,SEROPOSITIVE WOMEN,highly active antiretroviral therapy,HUMAN-IMMUNODEFICIENCY-VIRUS,HIGH-RISK,INFECTED WOMEN,SERONEGATIVE WOMEN,NATURAL-HISTORY,cervical neoplasia,HPV INFECTIONS},
  language     = {eng},
  number       = {6},
  pages        = {545--554},
  title        = {HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy},
  url          = {http://dx.doi.org/10.1097/CEJ.0b013e3282f75ea1},
  volume       = {17},
  year         = {2008},
}

Chicago
De Vuyst, Hugo, Flavia Lillo, Nathalie Broutet, and Jennifer S. Smith. 2008. “HIV, Human Papillomavirus, and Cervical Neoplasia and Cancer in the Era of Highly Active Antiretroviral Therapy.” European Journal of Cancer Prevention 17 (6): 545–554.
APA
De Vuyst, H., Lillo, F., Broutet, N., & Smith, J. S. (2008). HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. EUROPEAN JOURNAL OF CANCER PREVENTION, 17(6), 545–554.
Vancouver
1.
De Vuyst H, Lillo F, Broutet N, Smith JS. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. EUROPEAN JOURNAL OF CANCER PREVENTION. 2008;17(6):545–54.
MLA
De Vuyst, Hugo, Flavia Lillo, Nathalie Broutet, et al. “HIV, Human Papillomavirus, and Cervical Neoplasia and Cancer in the Era of Highly Active Antiretroviral Therapy.” EUROPEAN JOURNAL OF CANCER PREVENTION 17.6 (2008): 545–554. Print.